Comparison between Lenskart Solutions IPO and Sahajanand Medical Technologies IPO.
Lenskart Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sahajanand Medical Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Lenskart Solutions IPO is up to ₹7,278.02 Cr whereas the issue size of the Sahajanand Medical Technologies IPO is up to ₹0.00 Cr. The final issue price of Lenskart Solutions IPO is ₹402.00 per share and of Sahajanand Medical Technologies IPO is .
| Lenskart Solutions IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹382.00 per share | |
| Issue Price (Upper) | ₹402.00 per share | |
| Issue Price (Final) | ₹402.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ₹19.00 per share | |
| Market Lot Size | 37 shares | |
| Fresh Issue Size | 5,34,95,905 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹2,150.38 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 12,75,62,573 shares | 2,76,44,231 shares |
| OFS Issue Size (Amount) | up to ₹5,127.64 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,10,58,478 shares | 2,76,44,231 shares |
| Issue Size Total (Amount) | up to ₹7,278.02 Cr | up to ₹0.00 Cr |
Lenskart Solutions IPO opens on Oct 31, 2025, while Sahajanand Medical Technologies IPO opens on . The closing date of Lenskart Solutions IPO and Sahajanand Medical Technologies IPO is Nov 04, 2025, and , respectively.
| Lenskart Solutions IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Oct 30, 2025 | |
| Issue Open | Oct 31, 2025 | |
| Issue Close | Nov 04, 2025 | |
| Basis Of Allotment (Tentative) | Nov 06, 2025 | |
| Initiation of Refunds (Tentative) | Nov 07, 2025 | |
| Credit of Share (Tentative) | Nov 07, 2025 | |
| Listing date (Tentative) | Nov 10, 2025 | |
| Anchor Lockin End date 1 | Dec 05, 2025 | |
| Anchor Lockin End date 2 | Feb 03, 2026 |
Lenskart Solutions IPO P/E ratio is 227.27, as compared to Sahajanand Medical Technologies IPO P/E ratio of .
| Lenskart Solutions IPO | Sahajanand Medical Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Lenskart Solutions Ltd.'s revenue increased by 25% and profit after tax (PAT) rose by 3028% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Sahajanand Medical Technologies Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 442% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 19.85 | 40.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 17.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 227.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹69727.57 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 3.68% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.84 | 10.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 4.84 | 3.73% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Lenskart Solutions IPO Retail Individual Investors (RII) are offered 1,80,67,202 shares while in Sahajanand Medical Technologies IPO retail investors are offered 1,80,67,202 shares. Qualified Institutional Buyers (QIB) are offered 5,42,01,608 shares in Lenskart Solutions IPO and 0 shares in Sahajanand Medical Technologies IPO.
| Lenskart Solutions IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 8,13,02,412 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 5,42,01,608 shares | 0 shares |
| NII | 2,71,00,803 shares | 0 shares |
| RII | 1,80,67,202 shares | 0 shares |
| Employee | 3,91,644 shares | 0 shares |
| Others | ||
| Total | 18,10,63,669 shares | 0 shares |
Lenskart Solutions IPO subscribed 28.27x in total, whereas Sahajanand Medical Technologies IPO subscribed .
| Lenskart Solutions IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| QIB (times) | 40.36x | |
| NII (times) | 18.23x | |
| Big NII (times) | 21.81x | |
| Small NII (times) | 11.06x | |
| RII (times) | 7.56x | |
| Employee (times) | 4.96x | |
| Other (times) | ||
| Total (times) | 28.27x |
